Promote a Clinical Trial


Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia

RATIONALE: Romiplostim may cause the body to make platelets. PURPOSE: This randomized phase II trial is studying how well romiplostim works in treating hepatitis C-infected patients with thrombocytopenia.

Sponsored by: USC/Norris Comprehensive Cancer Center